Ubichem Approved for cGMP Radiolabelled API Production

02-Jun-2010 - Hungaria

Ubichem through its Hungarian operation - Ubichem Research - has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled active pharmaceutical ingredients (APIs).

Jozsef Repasi, Managing Director of Ubichem Research commented: “This approval enables us to supply radiolabelled materials for use in human clinical trials, and is a reflection of the skill and hard work of our dedicated team in Budapest, building on the approval obtained previously for the commercial supply of cGMP APIs.”

Other news from the department politics & laws

Most read news

More news from our other portals

Fighting cancer: latest developments and advances